vupanorsen

Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
Fierce Biotech
Mon, 01/31/22 - 10:47 am
Pfizer
vupanorsen
Ionis Pharmaceuticals
cholesterol
Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II
BioSpace
Fri, 11/26/21 - 08:49 pm
Akcea Therapeutics
Pfizer
clinical trials
triglycerides
vupanorsen
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Fierce Biotech
Wed, 11/24/21 - 10:15 am
Pfizer
Regeneron
antisense
clinical trials
vupanorsen
dyslipidemia
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol